Frontlight ResearchEarly access
Ovarian cancer trials in United States
348 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleMicrodevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
- Where
- Boston
- Age
- 18 years and over
- People
- 20
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT04701645 - No phaseTaking peopleThe Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
- Where
- Rochester
- Age
- 18 years and over
- People
- 12
- Run by
- New Phase Ltd.
See details and how to joinNCT07224464 - Phase 1/2Taking peopleACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- Where
- Aurora, Boston, Chicago, Columbus, Houston, Miami, New York, Philadelphia, Pittsburgh, Seattle, Stanford
- Age
- 18 years and over
- People
- 375 worldwide
- Run by
- Immatics US, Inc.
See details and how to joinNCT03686124 - Phase 2Taking peopleMaintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
- Where
- Indianapolis
- Age
- 18 years and over
- People
- 64
- Run by
- Nabil Adra
See details and how to joinNCT04804007 - No phaseTaking peoplePancreatic Cancer Genetics
- Where
- New York
- Age
- 18 years to 85 years
- People
- 100
- Run by
- Columbia University
See details and how to joinNCT01102569 - No phaseTaking peopleComparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Where
- Birmingham, Duarte, Fresno, Fruitdale, Fullerton, Honolulu, Las Vegas, Los Angeles, Mather, Mobile, Monterey, Palo Alto, Salt Lake City, San Francisco
- Age
- 18 years and over
- People
- 2,996
- Run by
- Stanford University
See details and how to joinNCT05297734 - Phase 1Taking peopleTrial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
- Where
- Houston
- Age
- 18 years and over
- People
- 18
- Run by
- Theolytics Limited
See details and how to joinNCT07211659 - Phase 3Taking peopleHeated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Where
- Abington, Albuquerque, Aurora, Austin, Chardon, Charleston, Cincinnati, Cleveland, Coral Gables, Deerfield Beach, Duarte, Durham, Fairfax, Hartford, Houston, Jefferson Hills, Kansas City, La Jolla, Lee's Summit, Lexington, Mentor, Miami, Milwaukee, Monroeville, Nashville, New Haven, New Orleans, Newport Beach, New York, Norfolk, Orange, Overland Park, Palo Alto, Pittsburgh, Plantation, Raleigh, Rochester, St Louis, Teaneck, West Chester, Westlake, Westwood, Wexford, Willow Grove, Wynnewood
- Age
- 18 years and over
- People
- 220
- Run by
- GOG Foundation
See details and how to joinNCT05659381 - No phaseTaking peopleREVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
- Where
- Aurora, Boston, Boulder, Durham
- Age
- 18 years and over
- People
- 240
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06710548 - No phaseTaking peopleThe SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
- Where
- Salt Lake City
- Age
- 21 years and over
- People
- 245
- Run by
- University of Utah
See details and how to joinNCT06665945 - Phase 1Taking peoplePhase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
- Where
- Austin, Fairfax, Plantation, San Antonio
- Age
- 18 years and over
- People
- 386
- Run by
- Conjupro Biotherapeutics, Inc.
See details and how to joinNCT07424547 - No phaseTaking peopleTUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
- Where
- Boston, Chicago, Durham, Houston, New York, Philadelphia, Rochester, Seattle, St Louis
- Age
- 25 years to 50 years
- People
- 3,000 worldwide
- Run by
- University Medical Center Nijmegen
See details and how to joinNCT04294927 - No phaseTaking peopleSurvivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
- Where
- Dallas, Houston
- Age
- 18 years and over
- People
- 120
- Run by
- Baylor College of Medicine
See details and how to joinNCT05752448 - Phase 1Taking peopleThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Where
- Austin, TX 78758, Boston, San Antonio
- Age
- 18 years and over
- People
- 100
- Run by
- Zumutor Biologics Inc.
See details and how to joinNCT06451497 - Phase 1/2Taking peopleOpen-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Where
- Atlanta, Augusta, Boston, Buffalo, Canton, Charlotte, Dallas, Detroit, Durham, Fort Wayne, Houston, Orlando, Tacoma
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- Incyclix Bio
See details and how to joinNCT05735080 - No phaseTaking peopleA Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 50
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05910294 - Phase 2Taking peopleStudy of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 86
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06290193 - No phaseTaking peopleSurvivors Uniting for Remote Guided Exercise
- Where
- Fort Collins
- Age
- 18 years and over
- People
- 300
- Run by
- Colorado State University
See details and how to joinNCT07290309 - Phase 1Taking peopleSafety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer
- Where
- Duarte
- Age
- 18 years and over
- People
- 8
- Run by
- PhotonPharma, Inc.
See details and how to joinNCT06366490 - Phase 1/2Taking peopleA Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Where
- Boston, Chicago, Columbus, Fairfax, Houston, Jacksonville, New Haven, New York, Philadelphia, Phoenix, Rochester, Salt Lake City, Seattle
- Age
- 18 years and over
- People
- 120
- Run by
- 858 Therapeutics, Inc.
See details and how to joinNCT06395519 - Phase 2Taking peopleAPL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion
- Where
- Buffalo
- Age
- 18 years and over
- People
- 60
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT04919629 - Phase 1/2Taking peopleCombination Therapy for Recurrent Ovarian Cancer
- Where
- Louisville
- Age
- 18 years and over
- People
- 72
- Run by
- Sham Sunder Kakar
See details and how to joinNCT05610735 - No phaseTaking peopleAccess to Genetic Testing in Underserved Patients With Cancer
- Where
- Los Angeles, Rochester
- Age
- 18 years and over
- People
- 800
- Run by
- University of Southern California
See details and how to joinNCT06422455 - Phase 1Taking peopleMUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer
- Where
- Scottsdale
- Age
- 18 years and over
- People
- 12
- Run by
- Mayo Clinic
See details and how to joinNCT06483048 - Phase 2Taking peopleComprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery
- Where
- Houston
- Age
- 18 years and over
- People
- 148
- Run by
- The Methodist Hospital Research Institute
See details and how to joinNCT07050771